UK Distribution · 16 September 2026

Lanson Group Appointed Exclusive UK Distributor for ACTXA Smart Health Wearables

Lanson Group has been appointed exclusive UK distributor for ACTXA, supporting the smart health wearable brand across UK retail, wholesale, e-retail and ecommerce.

We don't publish every development happening behind the scenes at Lanson Group - but some partnerships deserve a newsflash.

Lanson Group has been appointed the exclusive UK distributor for ACTXA, the Singapore-based preventive health technology company behind an expanding portfolio of smart health wearables. The appointment gives ACTXA a dedicated UK commercial and distribution route as the brand develops its presence across the British market.

Lanson Group is the exclusive UK distributor for ACTXA, supporting the smart health wearable brand across UK wholesale, retail, e-retail and ecommerce channels.

As ACTXA's UK distribution partner, Lanson Group will support the brand's continued development across wholesale, retail, e-retail, ecommerce, specialist health channels, marketplaces and trade accounts - providing a single, dedicated UK commercial and distribution route.

Who is ACTXA?

ACTXA is a Singapore-based deep tech company focused on AI-driven preventive health technology and smart wearables. Its approach centres on giving people clearer, everyday visibility of their health so they can act earlier - a preventive rather than reactive view of wellbeing.

The ACTXA Core Smart Ring

At the centre of the portfolio is the ACTXA Core Smart Ring - a featherlight smart health wearable built from aerospace-grade titanium and designed to be worn continuously. It captures health signals throughout the day and night and syncs to the ACTXA app for a single, unified view of the data.

The ACTXA Core Smart Ring tracks areas including:

• Sleep - stages, patterns and overall sleep quality
• Activity and meaningful movement
• Heart rate
• Heart rate variability (HRV)
• Blood oxygen (SpO2)
• Skin temperature trends
• Fitness and recovery indicators

AI Glucose Scan and BGEM technology

ACTXA has also developed its AI Glucose Scan, underpinned by its proprietary BGEM technology. In ACTXA's own words, the AI Glucose Scan provides a non-invasive view of glucose status through the analysis of biometric patterns, using clinically studied AI to interpret physiological signals captured through wearable sensors.

In short, the technology analyses the body's own signals to surface glucose-awareness insights - with no needles, strips or blood involved.

Important: ACTXA's AI Glucose Scan is designed for general wellness and lifestyle awareness. It is not a medical diagnostic tool and is not intended to diagnose diabetes, or to replace continuous glucose monitors, blood glucose meters or medical glucose testing.

ACTXA AI Glucose Scan - official information →

Building ACTXA's UK Retail and Distribution Network

ACTXA products may already be accessible to UK consumers online, but this partnership marks the next stage of ACTXA's structured development within the UK market. Rather than a first-time launch, it represents a deliberate step to expand and strengthen the brand's UK retail, wholesale, e-retail and distribution presence.

Lanson Group is ACTXA's exclusive UK distribution partner, developing the brand across every relevant route to market in the United Kingdom.

Working as ACTXA's UK distributor, Lanson Group will focus on:

• UK wholesale and distribution
• Retail development and retailer onboarding
• E-retailer and ecommerce development
• Marketplace support
• UK stock and fulfilment
• Trade account management
• Commercial and market development
• Long-term UK route-to-market strategy

This sits naturally within Lanson Group's broader healthcare, pharmacy, health technology and consumer distribution ecosystem - giving ACTXA access to established trade relationships and a partner that understands how to build a brand across UK channels, not simply move stock.

Explore Lanson Group's distribution and market-development services →

A Different Approach to Everyday Health Wearables

Wearable technology has traditionally concentrated on a familiar set of measures - steps, exercise and sleep. ACTXA is expanding that concept, bringing health, recovery, cardiovascular, sleep and glucose-awareness insights together within a single wearable ecosystem.

That broader approach runs across the ACTXA product range, including the ACTXA Core Smart Ring and the ACTXA Spark Band - unveiled at IFA Berlin 2026 - which combines daily health insights with non-invasive glucose awareness in a wristband form factor.

All product information here is based on ACTXA's official materials. For full, up-to-date specifications, visit the ACTXA website.

Visit the ACTXA website →

About Lanson Group

Lanson Group is a UK wholesale, distribution and market-development company working across healthcare, pharmacy, health technology, medical products, personal care and consumer brands - spanning retail, e-retail and ecommerce.

Lanson Group's model goes beyond simply warehousing or moving stock. The business works with brands to develop sustainable routes to market through wholesale, retail, ecommerce, e-retail, marketplaces and specialist sales channels - combining distribution, retail development and market development within one partner.

ACTXA now becomes part of Lanson Group's growing UK distribution and market-development ecosystem.

More news